Olanzapine in Patients With Advanced Cancer and Weight Loss

NCT00489593 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

57

Enrollment

OTHER

Sponsor class

Conditions

Advanced Cancer
Weight Loss

Interventions

DRUG: Olanzapine

Sponsor

M.D. Anderson Cancer Center